Elizabeth Tallett has spent more than 35 years in strategic leadership and operational roles in worldwide biopharmaceutical and consumer products industries, including as principal of Hunter Partners, President and CEO of Transcell Technologies Inc., President of Centocor Pharmaceuticals, and member of the Parke-Davis Executive Committee. In addition to serving on the Moderna Board of Directors, Ms. Tallett is currently the Chair of Elevance Health, Inc. (previously Anthem, Inc.) and she is a director of Qiagen, Inc. Ms. Tallett was a founding member of the Biotechnology Council of New Jersey and chairs the board of trustees at Solebury School in Pennsylvania. She was named a Financial Times Outstanding Director of the year in 2015 and recognized as one of the National Association of Corporate Directors (NACD) Directorship 100 honorees in 2019. She is a former director of Principal Financial Group, Meredith Group, Inc., Coventry Health Care, Inc., Varian, Inc., IntegraMed America Inc., and Varian SemiConductor Associates, Inc. Born and educated in England, Ms. Tallett graduated from Nottingham University with a dual first class honours degree in mathematics and economics.